ALGBE Global Bioenergies SA

Global Bioenergies rewarded by the rating organization EcoVadis for its CSR commitment

Global Bioenergies rewarded by the rating organization EcoVadis for its CSR commitment

PRESS RELEASE

Global Bioenergies rewarded by the rating organization EcoVadis for its CSR commitment

Evry, 12 October 2023 – 7:30 a.m.: In its first EcoVadis assessment, Global Bioenergies reached the top 30% of the most performing companies in terms of CSR among the 110,000 companies worldwide surveyed by the rating organization. The Company obtained the bronze medal. This award recognizes the company's sustainable development performance, orchestrated around 4 pillars: Environment, Social and Human Rights, Ethics and Responsible Purchasing.

Rym Khelif, CSR Project Manager at Global Bioenergies, comments: “We are on a trajectory aiming for exemplarity and many actions of course remain to be implemented and formalized. Nevertheless, we are progressing fast, as demonstrated by the two-fold improvement in the Gaïa assessment - a rating organization comparable to EcoVadis - between 2020 and 2022. Our latest example: we have cut our electricity consumption for our Evry laboratory by almost 30% over the last 24 months, saving the equivalent of 180MWh per year.

Marc Delcourt, Co-founder and CEO, adds: “The cosmetics industry is driven by a desire to improve CSR standards beyond naturalness, and at all levels of the industry, in order to establish itself as a reference for other major sectors of activity. As a supplier of cosmetic ingredients exchanging with the biggest names in the sector, the EcoVadis rating underlines our contribution to this effort and allows us to materialize our CSR commitment to our customers.

About GLOBAL BIOENERGIES

Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, the Company will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming. Global Bioenergies is listed on Euronext Growth in Paris (FR0011052257 - ALGBE). L'Oréal is its largest shareholder, with a 13.5% stake.

Contacts

GLOBAL BIOENERGIES

+33 (0)1 64 98 20 50





 



Follow our news



 



Receive information about Global Bioenergies directly by subscribing to our news feed on



 



 



Follow us on LinkedIn:





 
  



 



NewCap – Investor relations



Louis-Victor Delouvrier

Quentin Massé





+33 (0)1 44 71 94 94



 



 



NewCap – Media relations



 



Nicolas Merigeau



+33 (0)1 44 71 94 98

Attachment



EN
12/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Global Bioenergies SA

 PRESS RELEASE

Global Bioenergies publie son Document d’enregistrement universel 2023

Global Bioenergies publie son Document d’enregistrement universel 2023 COMMUNIQUE DE PRESSE Global Bioenergies publie son Document d’enregistrement universel 2023 Evry, le 23 avril 2024 – 18h30 : Global Bioenergies (FR0011052257 – ALGBE), acteur de la biologie industrielle, annonce aujourd’hui la publication de son Document d’enregistrement universel 2023, rendu disponible sur le site internet de la Société dans la rubrique « Investisseurs ». Ce document permet de présenter en détail la stratégie de la Société, des cosmétiques aux carburants d'aviation durables à partir d'une seule et mêm...

 PRESS RELEASE

Global Bioenergies certifiée ISO 9001

Global Bioenergies certifiée ISO 9001 COMMUNIQUE DE PRESSE Global Bioenergies certifiée ISO 9001 Evry, le 16 avril 2024 – 17h45 : Global Bioenergies (FR0011052257 – ALGBE), acteur de la biologie industrielle, annonce l’obtention de la certification ISO 9001:2015, reconnue à l’échelle mondiale en tant que référence en matière de qualité. Cette certification vient formaliser 3 ans d’efforts de la Société dans la mise en place de ses activités de production et de commercialisation. Ses objectifs principaux consistent à assurer la qualité des produits commercialisés et la satisfaction clients...

 PRESS RELEASE

Global Bioenergies has received letters of intent for its plant projec...

Global Bioenergies has received letters of intent for its plant project corresponding to forecasted annual sales of over €70 million PRESS RELEASE Global Bioenergies has received letters of intent for itsplant project corresponding to forecasted annual salesof over €70 million The plant will focus on high added-value cosmetics markets, with annual production capacity rescaled to 2,500 tons The total volume of letters of intent exceeds the plant's production capacityThe plant will also enable to initiate the sustainable aviation fuels market CAPEX and plant design specifications clarifi...

 PRESS RELEASE

Global Bioenergies a reçu des lettres d’intention pour son projet d’us...

Global Bioenergies a reçu des lettres d’intention pour son projet d’usine correspondant à un chiffre d’affaires annuel projeté de plus de 70 millions d’euros COMMUNIQUE DE PRESSE Global Bioenergies a reçu des lettres d’intention pour son projet d’usine correspondant à un chiffre d’affaires annuel projeté de plus de 70 millions d’euros L’usine se focalisera sur les marchés cosmétiques à haute valeur ajoutée avec une capacité de production annuelle redimensionnée à 2 500 tonnes Le volume total des lettres d’intention dépasse la capacité de production de l’usineL’usine permettra également...

 PRESS RELEASE

Global Bioenergies: strong reduction of the loss in 2023 thanks to a s...

Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity PRESS RELEASE Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity Sales exceeding €3M for the first timeConsolidated net loss significantly improved to -€8.7M compared to -€12M in 2022Gross cash position of €11.7M at 31 December 2023 compared to €8.8M the previous yearSuccessful commercialization of the first tons of Isonaturane™ 12 to several customers including L'OréalASTM certification received for the production o...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch